SCHEMBL24285974

SCHEMBL24285974

Nc1nc2ccc(-c3cnc4[nH]ccc4c3)cn2c1C=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RIPK1 Q13546 4/20 0.50
▸ CDK8 P49336 6/20 0.49
▸ AXL P30530 2/20 0.48
▸ PIK3CA P42336 3/20 0.47
▸ PIK3CD O00329 2/20 0.47
▸ PIK3CB P42338 2/20 0.47
▸ PIK3CG P48736 2/20 0.47
▸ LRRK2 Q5S007 2/20 0.43
▸ MAP4K1 Q92918 1/20 0.43
▸ CDK7 P50613 2/20 0.43
▸ CCNT1 O60563 1/20 0.43
▸ CCND1 P24385 1/20 0.43
▸ CCNC P24863 1/20 0.43
▸ CDK9 P50750 1/20 0.43
▸ CCNH P51946 1/20 0.43
▸ MNAT1 P51948 1/20 0.43
▸ CDK6 Q00534 1/20 0.43
▸ KDR P35968 3/20 0.42
▸ PLK4 O00444 2/20 0.42
▸ ROCK2 O75116 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24285859 0.82 CA12 (0.45) PIK3CAPIK3CDPIK3CBPIK3CGLRRK2
SCHEMBL29537181 0.77 RIPK1 (0.47) RIPK1CDK8AXLPIK3CAPIK3CD
SCHEMBL24285984 0.77 RIPK1 (0.47) RIPK1CDK8AXLPIK3CAPIK3CD
SCHEMBL29537003 0.75 LRRK2 (0.47) RIPK1CDK8AXLPIK3CAPIK3CD
SCHEMBL24285848 0.75 LRRK2 (0.47) RIPK1CDK8AXLPIK3CAPIK3CD
SCHEMBL22971695 0.75 CDK8 (0.72) RIPK1CDK8AXLPIK3CAPIK3CD
SCHEMBL29537513 0.74 RIPK1 (0.45) RIPK1CDK8AXLPIK3CAPIK3CD
SCHEMBL24285977 0.74 LRRK2 (0.59) RIPK1CDK8AXLPIK3CAPIK3CD
SCHEMBL24285867 0.74 RIPK1 (0.45) RIPK1CDK8AXLPIK3CAPIK3CD
SCHEMBL29537401 0.74 LRRK2 (0.59) RIPK1CDK8AXLPIK3CAPIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11744824-B2 2-amino-3-carbonyl imidazopyridine and pyrazolopyridine compounds 1ST Biotherapeutics, Inc. (KR) 2023-09-05 — — US disclosed
US-20220087985-A1 2-AMINO-3-CARBONYL IMIDAZOPYRIDINE AND PYRAZOLOPYRIDINE COMPOUNDS 1ST Biotherapeutics, Inc. (KR) 2022-03-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11744824-B2 2-amino-3-carbonyl imidazopyridine and pyrazolopyridine compounds NLRP3, NLRP1, KCNJ2 RIPK1 1112/4885CDK8 1745/4885AXL 4574/4885
US-20220087985-A1 2-AMINO-3-CARBONYL IMIDAZOPYRIDINE AND PYRAZOLOPYRIDINE COMPOUNDS NLRP3, NLRP1, KCNJ2 RIPK1 1112/4885CDK8 1745/4885AXL 4574/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback